{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:48:26Z","timestamp":1789015706329,"version":"build-2803163510"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Huntington\u2019s disease (HD) is a rare genetic neurodegenerative disorder caused by an expansion of CAG repeats in the Huntingtin (HTT) gene. One hypothesis suggests that the mutant HTT gene contributes to HD neuropathology through transcriptional dysregulation involving microRNAs (miRNAs). In particular, the miR-132\/212 cluster is strongly diminished in the HD brain. This study explores the effects of miR-132\/212 deficiency specifically in adult HD zQ175 mice. The absence of miR-132\/212 did not impact body weight, body temperature, or survival rates. Surprisingly, miR-132\/212 loss seemed to alleviate, in part, the effects on endogenous Htt expression, HTT inclusions, and neuronal integrity in HD zQ175 mice. Additionally, miR-132\/212 depletion led to age-dependent improvements in certain motor functions. Transcriptomic analysis revealed alterations in HD-related networks in WT- and HD zQ175-miR-132\/212-deficient mice, including significant overlap in BDNF and Creb1 signaling pathways. Interestingly, however, a higher number of miR-132\/212 gene targets was observed in HD zQ175 mice lacking the miR-132\/212 cluster, especially in the striatum. These findings suggest a nuanced interplay between miR-132\/212 expression and HD pathogenesis, providing potential insights into therapeutic interventions. Further investigation is needed to fully understand the underlying mechanisms and therapeutic potential of modulating miR-132\/212 expression during HD progression.<\/jats:p>","DOI":"10.3389\/fnins.2024.1421680","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T14:36:50Z","timestamp":1723041410000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Beneficial effects of miR-132\/212 deficiency in the zQ175 mouse model of Huntington\u2019s disease"],"prefix":"10.3389","volume":"18","author":[{"given":"Behnaz","family":"Nateghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi","family":"Keraudren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Boulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Goupil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Canet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9anne","family":"Loiselle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"St-Amour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Planel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Soulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien S.","family":"H\u00e9bert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1186\/s13041-019-0456-1","article-title":"Modulation of MTOR and CREB pathways following mGluR5 blockade contribute to improved Huntington\u2019s pathology in zQ175 mice.","volume":"12","author":"Abd-Elrahman","year":"2019","journal-title":"Mol. Brain"},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72613-3","article-title":"Osmolytes dynamically regulate mutant Huntingtin aggregation and CREB function in Huntington\u2019s disease cell models.","volume":"10","author":"Aravindan","year":"2020","journal-title":"Sci. Rep."},{"key":"B3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/bies.201100116","article-title":"A novel target for Huntington\u2019s disease: ERK at the crossroads of signaling. The ERK signaling pathway is implicated in Huntington\u2019s disease and its upregulation ameliorates pathology.","volume":"34","author":"Bodai","year":"2012","journal-title":"Bioessays"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.578720","article-title":"Advances and challenges in understanding MicroRNA function in tauopathies: A case study of miR-132\/212.","volume":"11","author":"Boscher","year":"2020","journal-title":"Front. Neurol."},{"key":"B5","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington\u2019s disease.","volume":"24","author":"Canals","year":"2004","journal-title":"J. Neurosci."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123527","article-title":"Characterization of HTT inclusion size, location, and timing in the zQ175 mouse model of Huntington\u2019s disease: An in vivo high-content imaging study.","volume":"10","author":"Carty","year":"2015","journal-title":"PLoS One"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00559","article-title":"Neuro-cardio mechanisms in Huntington\u2019s disease and other neurodegenerative disorders.","volume":"9","author":"Critchley","year":"2018","journal-title":"Front. Physiol."},{"key":"B8","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1073\/pnas.0801689105","article-title":"Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes in the absence of neurodegeneration.","volume":"105","author":"Cuellar","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mito.2023.03.001","article-title":"A comprehensive perspective of Huntington\u2019s disease and mitochondrial dysfunction.","volume":"70","author":"Dai","year":"2023","journal-title":"Mitochondrion"},{"key":"B10","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1523\/JNEUROSCI.4815-07.2008","article-title":"Conditional loss of dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus.","volume":"28","author":"Davis","year":"2008","journal-title":"J. Neurosci."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.705348","article-title":"Micrornas in Huntington\u2019s disease: Diagnostic biomarkers or therapeutic agents?","volume":"15","author":"Dong","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044060","article-title":"Gene network and pathway analysis of mice with conditional ablation of dicer in post-mitotic neurons.","volume":"7","author":"Dorval","year":"2012","journal-title":"PLoS One"},{"key":"B13","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1007\/s12035-021-02342-9","article-title":"Small non-coding RNAs are dysregulated in Huntington\u2019s disease transgenic mice independently of the therapeutic effects of an environmental intervention.","volume":"58","author":"Dubois","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"B14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00401-018-1880-5","article-title":"Microrna-132 provides neuroprotection for tauopathies via multiple signaling pathways.","volume":"136","author":"El Fatimy","year":"2018","journal-title":"Acta Neuropathol."},{"key":"B15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.omtn.2018.01.007","article-title":"Supplemental Treatment for Huntington\u2019s disease with miR-132 that Is Deficient in Huntington\u2019s Disease Brain.","volume":"11","author":"Fukuoka","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B16","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41593-018-0237-7","article-title":"Converging pathways in neurodegeneration, from genetics to mechanisms.","volume":"21","author":"Gan","year":"2018","journal-title":"Nat. Neurosci."},{"key":"B17","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington\u2019s disease: Relationship to neuropathology.","volume":"19","author":"Gutekunst","year":"1999","journal-title":"J. Neurosci."},{"key":"B18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00429-012-0431-4","article-title":"miRNA-132: A dynamic regulator of cognitive capacity.","volume":"218","author":"Hansen","year":"2012","journal-title":"Brain Struct. Funct."},{"key":"B19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1101\/lm.039578.115","article-title":"Targeted deletion of miR-132\/-212 impairs memory and alters the hippocampal transcriptome.","volume":"23","author":"Hansen","year":"2016","journal-title":"Learn. Mem."},{"key":"B20","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1093\/hmg\/ddq311","article-title":"Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration.","volume":"19","author":"Hebert","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.1038\/srep30953","article-title":"microRNA-132\/212 deficiency enhances Abeta production and senile plaque deposition in Alzheimer\u2019s disease triple transgenic mice.","volume":"6","author":"Hernandez-Rapp","year":"2016","journal-title":"Sci. Rep."},{"key":"B22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbr.2015.03.032","article-title":"Memory formation and retention are affected in adult miR-132\/212 knockout mice.","volume":"287","author":"Hernandez-Rapp","year":"2015","journal-title":"Behav. Brain Res."},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-022-01364-1","article-title":"The distribution and density of Huntingtin inclusions across the Huntington disease neocortex: Regional correlations with Huntingtin repeat expansion independent of pathologic grade.","volume":"10","author":"Hickman","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"B24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature09202","article-title":"Striatal microRNA controls cocaine intake through Creb signalling.","volume":"466","author":"Hollander","year":"2010","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mcn.2009.10.005","article-title":"An activity-induced microrna controls dendritic spine formation by regulating Rac1-PAK signaling.","volume":"43","author":"Impey","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"B26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/glia.23050","article-title":"Frequency of nuclear mutant Huntingtin inclusion formation in neurons and glia is cell-type-specific.","volume":"65","author":"Jansen","year":"2017","journal-title":"Glia"},{"key":"B27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.2559","article-title":"Sirt1 mediates neuroprotection from mutant Huntingtin by activation of the TORC1 and CREB transcriptional pathway.","volume":"18","author":"Jeong","year":"2011","journal-title":"Nat. Med."},{"key":"B28","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2007.11.001","article-title":"A microRNA-based gene dysregulation pathway in Huntington\u2019s disease.","volume":"29","author":"Johnson","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"B29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/2211536604666150813152620","article-title":"A microrna-BDNF negative feedback signaling loop in brain: Implications for Alzheimer\u2019s disease.","volume":"4","author":"Keifer","year":"2015","journal-title":"Microrna"},{"key":"B30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119565","article-title":"miRNA-132\/212 Deficiency disrupts selective corticosterone modulation of dorsal vs. ventral hippocampal metaplasticity.","volume":"24","author":"Kouhnavardi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2617979\/v1","article-title":"Small Molecule Regulators of micrornas Identified by high-throughput screen coupled with high-throughput sequencing.","author":"Krichevsky","year":"2023","journal-title":"Res. Sq."},{"key":"B32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2010.10.012","article-title":"Altered microrna regulation in Huntington\u2019s disease models.","volume":"227","author":"Lee","year":"2011","journal-title":"Exp. Neurol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00590","article-title":"Loss of miR-132\/212 has no long-term beneficial effect on cardiac function after permanent coronary occlusion in mice.","volume":"11","author":"Lei","year":"2020","journal-title":"Front. Physiol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-019-3105-x","article-title":"Mienturnet: An interactive web tool for microRNA-target enrichment and network-based analysis.","volume":"20","author":"Licursi","year":"2019","journal-title":"BMC Bioinform."},{"key":"B35","first-page":"143","article-title":"[Microrna-132 promotes atherosclerosis by inducing mitochondrial oxidative stressmediated ferroptosis].","volume":"42","author":"Liu","year":"2022","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"B36","doi-asserted-by":"crossref","first-page":"20382","DOI":"10.1073\/pnas.1015691107","article-title":"microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus.","volume":"107","author":"Magill","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng882","article-title":"Disruption of CREB function in brain leads to neurodegeneration.","volume":"31","author":"Mantamadiotis","year":"2002","journal-title":"Nat. Genet."},{"key":"B38","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.4103\/1673-5374.310673","article-title":"Altered microRNA expression in animal models of Huntington\u2019s disease and potential therapeutic strategies.","volume":"16","author":"Martinez","year":"2021","journal-title":"Neural Regen. Res."},{"key":"B39","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/hmg\/ddt499","article-title":"MeCP2: A novel Huntingtin interactor.","volume":"23","author":"McFarland","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175.","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004550","article-title":"Dysfunction of the CNS-heart axis in mouse models of Huntington\u2019s disease.","volume":"10","author":"Mielcarek","year":"2014","journal-title":"PLoS Genet."},{"key":"B42","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.neuint.2011.06.009","article-title":"Microrna function and neurotrophin BDNF.","volume":"59","author":"Numakawa","year":"2011","journal-title":"Neurochem. Int."},{"key":"B43","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-022-01407-7","article-title":"Widespread alterations in microRNA biogenesis in human Huntington\u2019s disease putamen.","volume":"10","author":"Petry","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"B44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neuroscience.2022.07.014","article-title":"Differential regulation of Tau Exon 2 and 10 isoforms in Huntington\u2019s disease brain.","volume":"518","author":"Petry","year":"2023","journal-title":"Neuroscience"},{"key":"B45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11010-016-2858-z","article-title":"Oxidative stress-induced CREB upregulation promotes DNA damage repair prior to neuronal cell death protection.","volume":"425","author":"Pregi","year":"2017","journal-title":"Mol. Cell. Biochem."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00770","article-title":"Advances in roles of miR-132 in the nervous system.","volume":"8","author":"Qian","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/BJ20100024","article-title":"Regulation of the miR-212\/132 locus by MSK1 and CREB in response to neurotrophins.","volume":"428","author":"Remenyi","year":"2010","journal-title":"Biochem. J."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062509","article-title":"miR-132\/212 knockout mice reveal roles for these miRNAs in regulating cortical synaptic transmission and plasticity.","volume":"8","author":"Remenyi","year":"2013","journal-title":"PLoS One"},{"key":"B49","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1016\/S1353-8020(09)70800-4","article-title":"Huntington disease: Pathogenesis, biomarkers, and approaches to experimental therapeutics.","volume":"15","author":"Ross","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"B50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington\u2019s disease: From molecular pathogenesis to clinical treatment.","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"B51","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.devcel.2014.07.006","article-title":"A self-organizing miR-132\/Ctbp2 circuit regulates bimodal notch signals and glial progenitor fate choice during spinal cord maturation.","volume":"30","author":"Salta","year":"2014","journal-title":"Dev. Cell"},{"key":"B52","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.15252\/emmm.201606520","article-title":"miR-132 loss de-represses ITPKB and aggravates amyloid and Tau pathology in Alzheimer\u2019s brain.","volume":"8","author":"Salta","year":"2016","journal-title":"Embo Mol. Med."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0253037","article-title":"A meta-analysis of transcriptomic profiles of Huntington\u2019s disease patients.","volume":"16","author":"Seefelder","year":"2021","journal-title":"PLoS One"},{"key":"B54","article-title":"Early detection of exon 1 Huntingtin aggregation in zQ175 brains by molecular and histological approaches.","volume":"5","author":"Smith","year":"2023","journal-title":"Brain Commun."},{"key":"B55","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1093\/hmg\/ddr330","article-title":"Microrna-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy.","volume":"20","author":"Smith","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B56","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1093\/hmg\/ddv377","article-title":"miR-132\/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo.","volume":"24","author":"Smith","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"B57","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/jnc.12090","article-title":"Dysregulation of Rest-regulated coding and non-coding RNAs in a cellular model of Huntington\u2019s disease.","volume":"124","author":"Soldati","year":"2013","journal-title":"J. Neurochem."},{"key":"B58","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1093\/hmg\/ddw212","article-title":"An enhanced Q175 knock-in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypes.","volume":"25","author":"Southwell","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B59","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00401-017-1786-7","article-title":"Co-occurrence of mixed proteinopathies in late-stage Huntington\u2019s disease.","volume":"135","author":"St-Amour","year":"2018","journal-title":"Acta Neuropathol."},{"key":"B60","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","article-title":"Expression profiling of Huntington\u2019s disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration.","volume":"27","author":"Strand","year":"2007","journal-title":"J. Neurosci."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01165","article-title":"intranasal delivery of targeted nanoparticles loaded with miR-132 to brain for the treatment of neurodegenerative diseases.","volume":"11","author":"Su","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B62","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-021-00755-1","article-title":"The regulatory roles of microRNAs toward pathogenesis and treatments in Huntington\u2019s disease.","volume":"28","author":"Tung","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"B63","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms2090","article-title":"The miRNA-212\/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy.","volume":"3","author":"Ucar","year":"2012","journal-title":"Nat. Commun."},{"key":"B64","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106829","article-title":"microRNA-132 regulates gene expression programs involved in microglial homeostasis.","volume":"26","author":"Walgrave","year":"2023","journal-title":"iScience"},{"key":"B65","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1093\/nar\/gks151","article-title":"miR-212\/132 expression and functions: Within and beyond the neuronal compartment.","volume":"40","author":"Wanet","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2015.00430","article-title":"Evidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment.","volume":"9","author":"Weinberg","year":"2015","journal-title":"Front. Neurosci."},{"key":"B67","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington\u2019s disease transgenic mice implicate PGC-1alpha in Huntington\u2019s disease neurodegeneration.","volume":"4","author":"Weydt","year":"2006","journal-title":"Cell Metab."},{"key":"B68","doi-asserted-by":"crossref","DOI":"10.4081\/ejh.2019.3008","article-title":"miR-132 regulates the expression of synaptic proteins in App\/Ps1 transgenic mice through C1q.","volume":"63","author":"Xu","year":"2019","journal-title":"Eur. J. Histochem."},{"key":"B69","first-page":"1673","article-title":"miR-132 regulates the differentiation of dopamine neurons by directly targeting Nurr1 expression.","volume":"125","author":"Yang","year":"2012","journal-title":"J. Cell Sci."},{"key":"B70","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1503\/jpn.130169","article-title":"BDNF-ERK-CREB signalling mediates the role of miR-132 in the regulation of the effects of oleanolic acid in male mice.","volume":"39","author":"Yi","year":"2014","journal-title":"J. Psychiatry Neurosci."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.687973","article-title":"Alzheimer\u2019s disease and microRNA-132: A Widespread pathological factor and potential therapeutic target.","volume":"15","author":"Zhang","year":"2021","journal-title":"Front. Neurosci."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00329","article-title":"A mitochondria-associated oxidative stress perspective on Huntington\u2019s disease.","volume":"11","author":"Zheng","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"B73","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of Huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease.","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2024.1421680\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T14:37:23Z","timestamp":1723041443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2024.1421680\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":73,"alternative-id":["10.3389\/fnins.2024.1421680"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2024.1421680","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]},"article-number":"1421680"}}